$DC
Dakota Gold Corp.

2023 Q4 Form 10-Q Financial Statement

#000106299323020466 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.459M $1.915M
YoY Change 10.53% -20.08%
% of Gross Profit
Research & Development $6.964M $6.945M
YoY Change 31.39% 48.46%
% of Gross Profit
Depreciation & Amortization $64.73K $113.4K
YoY Change 12.05% 111.41%
% of Gross Profit
Operating Expenses $9.423M $8.860M
YoY Change 25.22% 25.24%
Operating Profit -$8.860M
YoY Change 25.24%
Interest Expense $236.1K $58.06K
YoY Change 276.15%
% of Operating Profit
Other Income/Expense, Net $58.06K
YoY Change -235.16%
Pretax Income -$9.187M -$8.802M
YoY Change 23.11% 23.67%
Income Tax -$368.9K -$284.9K
% Of Pretax Income
Net Earnings -$8.818M -$8.543M
YoY Change 27.85% 29.91%
Net Earnings / Revenue
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$0.10 -$0.11
COMMON SHARES
Basic Shares Outstanding 86.74M shares 78.76M shares
Diluted Shares Outstanding 78.08M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.55M $12.76M
YoY Change 6.84% -54.56%
Cash & Equivalents $25.55M $12.76M
Short-Term Investments
Other Short-Term Assets $676.0K $539.5K
YoY Change 9.23% -30.05%
Inventory
Prepaid Expenses
Receivables $129.0K
Other Receivables $0.00
Total Short-Term Assets $26.22M $13.42M
YoY Change 6.44% -53.61%
LONG-TERM ASSETS
Property, Plant & Equipment $2.262M $2.002M
YoY Change 78.56% 55.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $371.9K $391.7K
YoY Change -2.31% 1858.25%
Total Long-Term Assets $81.98M $81.54M
YoY Change 1.98% 2.18%
TOTAL ASSETS
Total Short-Term Assets $26.22M $13.42M
Total Long-Term Assets $81.98M $81.54M
Total Assets $108.2M $94.97M
YoY Change 3.03% -12.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.705M $983.9K
YoY Change 54.39% -29.87%
Accrued Expenses $1.327M $1.051M
YoY Change 108.99% 73.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.486M $2.203M
YoY Change 78.39% 8.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $94.52K $127.3K
YoY Change
Total Long-Term Liabilities $94.52K $127.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.486M $2.203M
Total Long-Term Liabilities $94.52K $127.3K
Total Liabilities $4.666M $2.789M
YoY Change 21.29% -30.06%
SHAREHOLDERS EQUITY
Retained Earnings -$42.66M -$33.85M
YoY Change 586.42% -5068.59%
Common Stock $86.74K $79.07K
YoY Change 18.27% 9.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.5M $92.18M
YoY Change
Total Liabilities & Shareholders Equity $108.2M $94.97M
YoY Change 3.03% -12.67%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$8.818M -$8.543M
YoY Change 27.85% 29.91%
Depreciation, Depletion And Amortization $64.73K $113.4K
YoY Change 12.05% 111.41%
Cash From Operating Activities -$5.993M -$8.169M
YoY Change -1.45% 33.37%
INVESTING ACTIVITIES
Capital Expenditures $537.3K $544.0K
YoY Change 92.19% -163.54%
Acquisitions
YoY Change
Other Investing Activities -$2.820K -$95.75K
YoY Change
Cash From Investing Activities -$540.1K -$639.8K
YoY Change 93.2% -25.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.33M 6.124M
YoY Change 777.14% 81555.2%
NET CHANGE
Cash From Operating Activities -5.993M -8.169M
Cash From Investing Activities -540.1K -639.8K
Cash From Financing Activities 19.33M 6.124M
Net Change In Cash 12.79M -2.684M
YoY Change -407.76% -61.51%
FREE CASH FLOW
Cash From Operating Activities -$5.993M -$8.169M
Capital Expenditures $537.3K $544.0K
Free Cash Flow -$6.530M -$8.713M
YoY Change 2.67% 65.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-541187 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8542662 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6575955 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21632 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
90554 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
111189358 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3239342 usd
CY2022Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-5808725 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0307 pure
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
128988 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
107356 usd
us-gaap Exploration Costs
ExplorationCosts
21381844 usd
us-gaap Exploration Costs
ExplorationCosts
9666629 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7231744 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12125899 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28613588 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21792528 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-873977 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7063654 usd
us-gaap Profit Loss
ProfitLoss
-27631453 usd
us-gaap Profit Loss
ProfitLoss
-14578975 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3453900 usd
us-gaap Net Income Loss
NetIncomeLoss
-27631453 usd
us-gaap Net Income Loss
NetIncomeLoss
-11125075 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
dc Payments Of Income Taxes On Restricted Stock Units And Performance Stock Units
PaymentsOfIncomeTaxesOnRestrictedStockUnitsAndPerformanceStockUnits
263214 usd
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
144302330 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37500 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000 usd
CY2023Q3 dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
162042 usd
CY2022Q3 dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
188816 usd
dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
572886 usd
dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
1039628 usd
CY2023Q3 dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
738827 usd
dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
4810583 usd
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
900869 usd
dc Share Based Payment Arrangement Non Vested Award Option Restricted Stock Units
ShareBasedPaymentArrangementNonVestedAwardOptionRestrictedStockUnits
783284 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.89
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M4D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
937420 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
333588 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y29D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
570938 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3187565 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M7D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
570938 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4201910 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-28089 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19513 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
161839 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
169412 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
133750 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
149899 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28479838 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21642629 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
25592 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75971667 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75971667 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71414721 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71414721 shares
dc Payments To Acquire Reclamation Deposit Paid
PaymentsToAcquireReclamationDepositPaid
0 usd
dc Payments To Acquire Reclamation Deposit Paid
PaymentsToAcquireReclamationDepositPaid
20000 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
95747 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
0 usd
dc Issuance Of Common Stock On Acquisition Of Non Controlling Interest
IssuanceOfCommonStockOnAcquisitionOfNonControllingInterest
0 usd
dc Issuance Of Common Stock On Acquisition Of Non Controlling Interest
IssuanceOfCommonStockOnAcquisitionOfNonControllingInterest
48799274 usd
CY2023Q2 dc Stock Issued During Period Value Common Stock Issued For Amortized Issuance Costs
StockIssuedDuringPeriodValueCommonStockIssuedForAmortizedIssuanceCosts
4484105 usd
CY2023Q2 dc Payments Of Income Taxes On Rsus
PaymentsOfIncomeTaxesOnRsus
-225214 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1256498 usd
CY2023Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-9822760 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1600000 usd
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2194295 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1922517 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109960197 usd
CY2022Q3 dc Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
7503 usd
CY2022Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
675000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
688352 usd
CY2022Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-6575955 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
104755097 usd
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
79149401 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
78737287 usd
CY2022Q3 us-gaap Depreciation
Depreciation
53432 usd
us-gaap Depreciation
Depreciation
132243 usd
CY2022Q3 dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
499536 usd
dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
2877215 usd
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
688352 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3450101 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5850211 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y4M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3999572 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
62500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.34
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
68750 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.05
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4201910 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.86
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0 usd

Files In Submission

Name View Source Status
dc-20230930_cal.xml Edgar Link unprocessable
0001062993-23-020466-index-headers.html Edgar Link pending
0001062993-23-020466-index.html Edgar Link pending
0001062993-23-020466.txt Edgar Link pending
0001062993-23-020466-xbrl.zip Edgar Link pending
dc-20230930.xsd Edgar Link pending
dc-20230930_def.xml Edgar Link unprocessable
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dc-20230930_lab.xml Edgar Link unprocessable
dc-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed